Back to Journals » Drug Design, Development and Therapy » Volume 16
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,973 | Dovepress* | 5,827+ | 374 | 6,201 | |
PubMed Central* | 146 | 87 | 233 | ||
Totals | 5,973 | 461 | 6,434 | ||
*Since 16 May 2022 |
View citations on PubMed Central and Google Scholar